(Total Views: 357)
Posted On: 05/17/2019 10:29:15 AM
Post# of 72447
totally understand and agree
but what most here are forgetting is the time frame in place by NR
4 years and 5 months ($5 to $2.50 to $1.25 to 60c to 70c to 30c to 35c and so on)
edited in .. yesterday's post and correction
https://investorshangout.com/post/view?id=5438746
https://investorshangout.com/post/view?id=5438769
as i've noted numerous x .. 99.99% of OTC targets do not survive let alone outlast
Innovation Pharma's investors are an asset
Innovation Pharma's diverse platform/s (potential) are an asset
Innovation Pharma's I/O is an asset (Float is what is freely traded)
NR had no choice but to let the helium out of IPIX's balloon last week
because if they hadn't IPIX would have had a 10M~ *volume* day yesterday
and odds are a revisit to around 70c
this is why *volume* is the key .. and understanding why NR would *hire* new decoys for blocking on ask
this will remain a war *imo* until Innovation Pharma uplists out of the OTC cesspool of TOXIC FILTH
then my expectation is IPIX may very well follow the *handling* of AMRN
with IPIX having a slight premium price wise on *handling* due to our I/O
just remember .. in the last round of money cycles NR worked on CTIX (2014)
that would have translated to over 50M~ in daily volume on IPIX for this round
4kids
They have to know that when IPIX gets the deal inked with an upfront payment NR is toast. Just because many of us already have the bulk of a position that we're happy with, add in the excitement of follow through and many of us will willingly add in more knowing we're going through the roof. And then add in the big guns when they see that 'lil 'ole OTC IPIX is about to rip on to uplisting.
That happens? This'll be nuts.
but what most here are forgetting is the time frame in place by NR
4 years and 5 months ($5 to $2.50 to $1.25 to 60c to 70c to 30c to 35c and so on)
edited in .. yesterday's post and correction
https://investorshangout.com/post/view?id=5438746
https://investorshangout.com/post/view?id=5438769
as i've noted numerous x .. 99.99% of OTC targets do not survive let alone outlast
Innovation Pharma's investors are an asset
Innovation Pharma's diverse platform/s (potential) are an asset
Innovation Pharma's I/O is an asset (Float is what is freely traded)
NR had no choice but to let the helium out of IPIX's balloon last week
because if they hadn't IPIX would have had a 10M~ *volume* day yesterday
and odds are a revisit to around 70c
this is why *volume* is the key .. and understanding why NR would *hire* new decoys for blocking on ask
this will remain a war *imo* until Innovation Pharma uplists out of the OTC cesspool of TOXIC FILTH
then my expectation is IPIX may very well follow the *handling* of AMRN
with IPIX having a slight premium price wise on *handling* due to our I/O
just remember .. in the last round of money cycles NR worked on CTIX (2014)
that would have translated to over 50M~ in daily volume on IPIX for this round
4kids
They have to know that when IPIX gets the deal inked with an upfront payment NR is toast. Just because many of us already have the bulk of a position that we're happy with, add in the excitement of follow through and many of us will willingly add in more knowing we're going through the roof. And then add in the big guns when they see that 'lil 'ole OTC IPIX is about to rip on to uplisting.
That happens? This'll be nuts.
(4)
(0)
